drugset / Trial / NCT00755560
Treatment of Asymptomatic Toxocariasis With Albendazole in Children
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to evaluate effectiveness of albendazole in the treatment of the asymptomatic infection with the parasite Toxocara in children. Treatment response is defined as a reduction in the number of eosinophils in blood. The study drug will be compared to placebo and randomly assigned in a double blind manner. Follow up will be prospective. 50 children (25 per group) will be enrolled in the study.
Timeline
- Start
- 2008-09
- Primary completion
- 2015-07
- Completion
- 2025-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albendazole | Small molecule | 10 mg/kg | — |
| Comparator | Albendazole | Small molecule | 15 mg/kg | — |